Medical imaging managers have very low confidence about receiving adequate reimbursement from Medicare, according to the latest MICI report.
Continuing the trend of concern over reimbursement, medical imaging administrators reported having “very low confidence” that they will be adequately reimbursed from Medicare.
The latest Medical Imaging Confidence Index (MICI) data showed that medical imaging managers are even more discouraged about reimbursement than this time last year, when the confidence score was 66. The confidence score for the first quarter of 2014 was a mere 57. The index evaluated the outlooks of 178 hospital imaging directors and managers.
Managers are confident that internal operating and staff costs will remain constant and their departments will maintain or grow as a profit center. The consensus on monthly growth in diagnostic and interventional radiology is neutral. But managers did show concern about having access to capital for imaging equipment and IT needs.
Here are the full results for the first quarter of 2014:
What do you think?
Medical Imaging Confidence Index (MICI) was co-developed by AHRA: The Association for Medical Imaging Management and The MarkeTech Group, owner of the imagePRO panel, launched in 2008. MICI data rely on the feedback of a statistical cohort of respondents from the imagePRO panel that accurately represent the US market hospital market by bedsize and geographic areas.
For more on the MICI, check out the FAQ here.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.